23andMe Founder Wojcicki Agrees to Pay $305 Million to Buy Bankrupt Business
Wojcicki outbids Regeneron, a pharmaceutical company that agreed to buy 23andMe’s assets last month.
Start your morning with the important global tech news of the day, covered by The Information team across five time zones.